Stacy Grieve

562 total citations
27 papers, 352 citations indexed

About

Stacy Grieve is a scholar working on Molecular Biology, Cell Biology and Hematology. According to data from OpenAlex, Stacy Grieve has authored 27 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cell Biology and 5 papers in Hematology. Recurrent topics in Stacy Grieve's work include Hippo pathway signaling and YAP/TAZ (6 papers), Multiple Myeloma Research and Treatments (3 papers) and Ubiquitin and proteasome pathways (3 papers). Stacy Grieve is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (6 papers), Multiple Myeloma Research and Treatments (3 papers) and Ubiquitin and proteasome pathways (3 papers). Stacy Grieve collaborates with scholars based in Canada, United States and United Kingdom. Stacy Grieve's co-authors include Xiaolong Yang, Dulcie Lai, Tony Reiman, Y Hao, Peter A. Greer, Christine Hall, Jing Hu, Nicolas Crapoulet, Gabriel Wajnberg and Simi Chacko and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Oncogene.

In The Last Decade

Stacy Grieve

25 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stacy Grieve Canada 10 168 85 75 55 43 27 352
Llana Pootrakul United States 8 165 1.0× 91 1.1× 72 1.0× 35 0.6× 14 0.3× 14 347
Lihua Shao China 8 281 1.7× 51 0.6× 87 1.2× 77 1.4× 19 0.4× 15 464
Audra N. Iness United States 11 230 1.4× 27 0.3× 85 1.1× 56 1.0× 52 1.2× 17 413
Gabriela Mustata Wilson United States 10 153 0.9× 28 0.3× 48 0.6× 38 0.7× 15 0.3× 21 315
Hiroshi Kumimoto Japan 11 245 1.5× 37 0.4× 54 0.7× 74 1.3× 55 1.3× 17 423
Sanae Uchida Japan 11 449 2.7× 107 1.3× 128 1.7× 33 0.6× 46 1.1× 15 586
Fumi Kobayashi Japan 8 165 1.0× 173 2.0× 35 0.5× 25 0.5× 18 0.4× 20 395
Yousef Binamer Saudi Arabia 12 96 0.6× 55 0.6× 49 0.7× 48 0.9× 35 0.8× 43 336
Mari Kaarbø Norway 9 215 1.3× 25 0.3× 34 0.5× 72 1.3× 46 1.1× 19 408
Alexandra Kuzyk Canada 11 150 0.9× 19 0.2× 46 0.6× 19 0.3× 18 0.4× 22 318

Countries citing papers authored by Stacy Grieve

Since Specialization
Citations

This map shows the geographic impact of Stacy Grieve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacy Grieve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacy Grieve more than expected).

Fields of papers citing papers by Stacy Grieve

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stacy Grieve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacy Grieve. The network helps show where Stacy Grieve may publish in the future.

Co-authorship network of co-authors of Stacy Grieve

This figure shows the co-authorship network connecting the top 25 collaborators of Stacy Grieve. A scholar is included among the top collaborators of Stacy Grieve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacy Grieve. Stacy Grieve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grieve, Stacy, George S. Baillie, Kazem Nouri, et al.. (2025). Quantification and structure–function analysis of calpain-1 and calpain-2 protease subunit interactions. Journal of Biological Chemistry. 301(6). 110243–110243. 1 indexed citations
2.
Sands, Bruce E., Silvio Danese, John C. Chapman, et al.. (2024). Mucosal and Transmural Healing and Long-term Outcomes in Crohn’s Disease. Inflammatory Bowel Diseases. 31(3). 857–877. 12 indexed citations
3.
Mease, Philip J., Dafna D. Gladman, Joseph F. Merola, et al.. (2024). Comparative efficacy and safety of bimekizumab in psoriatic arthritis: a systematic literature review and network meta-analysis. Lara D. Veeken. 63(7). 1779–1789. 6 indexed citations
4.
Grieve, Stacy, et al.. (2024). TAZ downregulated ANXA1 expression to modulate myeloma cell interactions with bone marrow mesenchymal stromal cells. Experimental Hematology. 138. 104282–104282.
5.
Paoli, Carly J., et al.. (2024). Effectiveness of Single-Tablet Combination Therapy in Improving Adherence and Persistence and the Relation to Clinical and Economic Outcomes. Journal of health economics and outcomes research. 8–22. 6 indexed citations
6.
Grieve, Stacy, et al.. (2023). TAZ upregulates MIR‐224 to inhibit oxidative stress response in multiple myeloma. Cancer Reports. 6(10). e1879–e1879. 4 indexed citations
8.
Panaccione, Remo, Wan‐Ju Lee, Kristina Kligys, et al.. (2023). Dose Escalation Patterns of Advanced Therapies in Crohn’s Disease and Ulcerative Colitis: A Systematic Literature Review. Advances in Therapy. 40(5). 2051–2081. 13 indexed citations
9.
Patel, Vihas, et al.. (2023). SA12 Use of Living Systematic Reviews (LSRS) Beyond COVID-19. Value in Health. 26(6). S399–S399. 1 indexed citations
10.
Mease, Philip J., Dafna D. Gladman, Joseph F. Merola, et al.. (2023). SA64 Comparative Effectiveness of Bimekizumab in Patients with Psoriatic Arthritis: Results from a Systematic Literature Review and Network Meta-Analysis. Value in Health. 26(6). S408–S408. 3 indexed citations
11.
Grieve, Stacy, et al.. (2023). MST1 downregulates TAZ tumor suppressor protein in multiple myeloma and is a potential therapeutic target. Experimental Hematology. 123. 34–45. 5 indexed citations
12.
Kennedy, Barry E., Michael Giacomantonio, J. Patrick Murphy, et al.. (2022). NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma. Molecular Therapy — Oncolytics. 24. 695–706. 6 indexed citations
13.
Halpin, David, et al.. (2022). Epidemiology, Healthcare Resource Utilization, and Mortality of Asthma and COPD in COVID-19: A Systematic Literature Review and Meta-Analyses. Journal of Asthma and Allergy. Volume 15. 811–825. 19 indexed citations
15.
Grieve, Stacy, et al.. (2020). Targeting NK Cell Inhibitory Receptors for Precision Multiple Myeloma Immunotherapy. Frontiers in Immunology. 11. 575609–575609. 40 indexed citations
16.
Grieve, Stacy, Keyue Ding, Faisal Hossain, et al.. (2020). Immunohistochemical validation study of 15-gene biomarker panel predictive of benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of JBR.10. ESMO Open. 5(2). e000679–e000679. 6 indexed citations
17.
Grieve, Stacy, Yan Gao, Christine Hall, Jing Hu, & Peter A. Greer. (2016). Calpain Genetic Disruption and HSP90 Inhibition Combine To Attenuate Mammary Tumorigenesis. Molecular and Cellular Biology. 36(15). 2078–2088. 21 indexed citations
18.
Liu, Jun, Stacy Grieve, Benjamin Yeung, et al.. (2013). Insulin activates the insulin receptor to downregulate the PTEN tumour suppressor. Oncogene. 33(29). 3878–3885. 24 indexed citations
19.
Lai, Dulcie, Stacy Grieve, & Xiaolong Yang. (2012). Tumour suppressor genes in chemotherapeutic drug response. Bioscience Reports. 32(4). 361–374. 78 indexed citations
20.
Grieve, Stacy, Y Hao, & Xiaolong Yang. (2011). Human homolog of Drosophila expanded, hEx, functions as a putative tumor suppressor in human cancer cell lines independently of the Hippo pathway. Oncogene. 31(9). 1189–1195. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026